| P2093 | author name string | Alberto Garcia-Hernandez | |
| P2860 | cites work | A review and classification of approaches for dealing with uncertainty in multi-criteria decision analysis for healthcare decisions | Q28084751 |
| | Two approaches to incorporate clinical data uncertainty into multiple criteria decision analysis for benefit-risk assessment of medicinal products | Q30843069 |
| | Understanding risk and lessons for clinical risk communication about treatment preferences | Q34354176 |
| | A quantitative approach to benefit-risk assessment of medicines - part 1: the development of a new model using multi-criteria decision analysis | Q36839228 |
| | A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group | Q37735945 |
| | Multiple criteria decision analysis for health technology assessment | Q38067863 |
| | Balancing benefit and risk of medicines: a systematic review and classification of available methodologies | Q38211405 |
| | Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy. | Q38480052 |
| | The standard gamble method: what is being measured and how it is interpreted | Q40658208 |
| | A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment | Q41512521 |
| | A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis. | Q44827816 |
| | Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer | Q45835107 |
| | American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis | Q47643186 |
| | Quality-of-life-adjusted hazard of death: a formulation of the quality-adjusted life-years model of use in benefit-risk assessment | Q48082835 |
| | A case study using the PrOACT-URL and BRAT frameworks for structured benefit risk assessment. | Q48232237 |
| | Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy. | Q51132121 |
| | On the elicitation of preferences for alternative therapies. | Q52875159 |
| | Correcting biases in standard gamble and time tradeoff utilities. | Q52967121 |
| | The construction of standard gamble utilities. | Q53020473 |
| | Patient utilities in fibromyalgia and the association with other outcome measures. | Q53640667 |
| P433 | issue | 11 | |
| P921 | main subject | decision analysis | Q5249226 |
| P304 | page(s) | 1049-1057 | |
| P577 | publication date | 2015-09-09 | |
| P1433 | published in | Drug Safety | Q15724462 |
| P1476 | title | A Note on the Validity and Reliability of Multi-Criteria Decision Analysis for the Benefit-Risk Assessment of Medicines | |
| P478 | volume | 38 | |